Andrew Ridley, Ph.D., joins Hannah to discuss Cellink's achievement in winning the New Product Award at SLAS Europe 2022. Ridley explains what 3D bioprinting is and how BIO CELLX, the innovative biodispenser from Cellink, is shaping the future of drug discovery and tissue engineering. Also, Ridley shares a glimpse into what Cellink has in store for future products and how Cellink can provide to anyone wanting to use their technology without any tissue engineering experience.
To learn more about Cellink, visit: https://www.cellink.com/
About Andrew Ridley, Ph.D.:
Ridley is an experienced Product Manager/Sales Director with a Ph.D. focused in Molecular and Cellular Biology and has a history of working in the biotechnology industry. Skilled in molecular/cell biology with a focus on cutting-edge technologies including microfluidics and 3D bioprinting.
Stay connected with SLAS:
About SLAS:
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building. For more information about SLAS, visit www.slas.org.
SLAS publishes two peer-reviewed and MEDLINE-indexed scientific journals, SLAS Discovery and SLAS Technology. For more information about SLAS and its journals, visit www.slas.org/publications.
Upcoming SLAS Events:
SLAS 2022 Americas Sample Management Symposium
SLAS 2022 AI Data Pipelines for Life Sciences Symposium
SLAS 2022 Bio Entrepreneurship Symposium
Upcoming SLAS Events:
SLAS Building Biology in 3D Symposium
SLAS Europe 2024 Conference and Exhibition